J. Buret

651 total citations
10 papers, 187 citations indexed

About

J. Buret is a scholar working on Infectious Diseases, Genetics and Epidemiology. According to data from OpenAlex, J. Buret has authored 10 papers receiving a total of 187 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 2 papers in Genetics and 2 papers in Epidemiology. Recurrent topics in J. Buret's work include Inflammation biomarkers and pathways (1 paper), HIV Research and Treatment (1 paper) and Diphtheria, Corynebacterium, and Tetanus (1 paper). J. Buret is often cited by papers focused on Inflammation biomarkers and pathways (1 paper), HIV Research and Treatment (1 paper) and Diphtheria, Corynebacterium, and Tetanus (1 paper). J. Buret collaborates with scholars based in France, Belgium and Netherlands. J. Buret's co-authors include Marie Skarzynski, D. Perrotin, Armelle Mathonnet, Denis Garot, Thierry Boulain, Stéphan Ehrmann, Emmanuelle Mercier, Anne Bretagnol, Dalila Benzékri-Lefèvre and J Badin and has published in prestigious journals such as Journal of Hepatology, Journal of Antimicrobial Chemotherapy and Critical Care.

In The Last Decade

J. Buret

9 papers receiving 184 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Buret France 5 72 58 55 50 40 10 187
Omar Mehkri United States 6 41 0.6× 66 1.1× 76 1.4× 52 1.0× 17 0.4× 14 190
Nagapradeep Nagajothi United States 9 49 0.7× 89 1.5× 193 3.5× 58 1.2× 41 1.0× 13 336
E. Ghrenassia France 7 20 0.3× 24 0.4× 44 0.8× 66 1.3× 10 0.3× 14 178
S. De Castro Italy 3 40 0.6× 10 0.2× 20 0.4× 93 1.9× 15 0.4× 3 171
Shih-Meng Yeh Taiwan 5 39 0.5× 120 2.1× 17 0.3× 183 3.7× 7 0.2× 6 319
Zoltán Ondrik Hungary 7 30 0.4× 72 1.2× 24 0.4× 75 1.5× 10 190
Samit Jain India 11 169 2.3× 14 0.2× 39 0.7× 95 1.9× 2 0.1× 33 295
Pranaw Kumar Jha India 8 48 0.7× 101 1.7× 17 0.3× 38 0.8× 32 200
Israel Grilo Bensusán Spain 7 105 1.5× 4 0.1× 49 0.9× 193 3.9× 15 0.4× 12 315
Anaïs Curtiaud France 10 42 0.6× 11 0.2× 107 1.9× 39 0.8× 1 0.0× 20 238

Countries citing papers authored by J. Buret

Since Specialization
Citations

This map shows the geographic impact of J. Buret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Buret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Buret more than expected).

Fields of papers citing papers by J. Buret

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Buret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Buret. The network helps show where J. Buret may publish in the future.

Co-authorship network of co-authors of J. Buret

This figure shows the co-authorship network connecting the top 25 collaborators of J. Buret. A scholar is included among the top collaborators of J. Buret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Buret. J. Buret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Sève, Aymeric, Laurent Hocqueloux, Christian Mille, et al.. (2017). Quel schéma vaccinal pour la population migrante en France : schéma complet ou rappel ? Intérêt du tétanos quick test. Médecine et Maladies Infectieuses. 47(4). S132–S132.
2.
Gubavu, C., Thiérry Prazuck, Mohamadou Niang, et al.. (2015). Dolutegravir-based monotherapy or dual therapy maintains a high proportion of viral suppression even in highly experienced HIV-1-infected patients. Journal of Antimicrobial Chemotherapy. 71(4). 1046–1050. 48 indexed citations
3.
Hocqueloux, Laurent, Xavier Causse, Antoine Valéry, et al.. (2015). The high burden of hospitalizations for primary EBV infection: a 6-year prospective survey in a French hospital. Clinical Microbiology and Infection. 21(11). 1041.e1–1041.e7. 11 indexed citations
4.
Vandenhende, M.A., J. Buret, Fabrice Camou, Philippe Morlat, & Fabrice Bonnet. (2014). Successful daptomycin lock therapy for implantable intra-arterial catheter infection in a patient with liver metastases of colon cancer. Diagnostic Microbiology and Infectious Disease. 78(4). 497–498. 3 indexed citations
5.
Hocqueloux, Laurent, J. Buret, Frédéric Lagarde, et al.. (2013). 323 DURING PRIMARY EBV INFECTION, THE INTENSITY OF LIVER ABNORMALITIES CORRELATES WITH AGE AND IMMUNE RESPONSE, AND THE USE OF CORTICOSTEROIDS IS NOT DELETERIOUS. Journal of Hepatology. 58. S135–S135. 1 indexed citations
6.
Badin, J, Thierry Boulain, Stéphan Ehrmann, et al.. (2011). Relation between mean arterial pressure and renal function in the early phase of shock: a prospective, explorative cohort study. Critical Care. 15(3). R135–R135. 100 indexed citations
7.
Debiais, Séverine, et al.. (2008). Efficacy of Anakinra in a Case of Refractory Still Disease. JCR Journal of Clinical Rheumatology. 14(6). 357–358. 15 indexed citations
8.
Buret, J., M. Marcq, Yvon Lebranchu, et al.. (2008). Difficultés de la prise en charge d’une forme pulmonaire isolée du syndrome de Goodpasture. Revue des Maladies Respiratoires. 25(3). 323–327. 3 indexed citations
9.
Buret, J., et al.. (1986). [Significance of lactate dehydrogenases in pleural effusions].. PubMed. 42(2). 74–81. 5 indexed citations
10.
Buret, J., et al.. (1972). Le concept "Valeur Normale" en chimie clinique. RMLG. Revue médicale de Liège. 27(1). 1–20. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026